InsiderTradr

ChemoMetec A/S (0DZ0.IL)

IOB · DKK · Healthcare · Medical Devices

DKK 608.25 (+2.40%) as of

Key statistics

Market cap
12.56B
P/E (TTM)
59.28
EPS (TTM)
10.26
Dividend yield
2.12%
52-week range
236.00 – 799.25
Beta
1.28
Revenue (TTM)
444.4M
Profit margin
40.20%
Volume
1.16k

About ChemoMetec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension. In addition, the company provides consumables comprising cassettes, reagents, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

Sector
Healthcare
Industry
Medical Devices
Headquarters
Allerød, Denmark
Employees
167

chemometec.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks